temozolomide has been researched along with 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Asab, M; Celiku, O; Chen, LY; Chen, R; Estok, T; Gilbert, MR; Lappin, H; Larion, M; Li, A; Lita, A; Maric, D; Meetze, K; Song, H; Su, YT; Vasconcelos, G; Wang, H; Wu, J; Yang, C; Zhang, Q; Zhang, W; Zhuang, Z | 1 |
1 other study(ies) available for temozolomide and 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
| Article | Year |
|---|---|
Novel Targeting of Transcription and Metabolism in Glioblastoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Energy Metabolism; Glioblastoma; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, Inbred C57BL; Temozolomide; Transcription, Genetic | 2018 |